🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Post-induction hypotension (PIH) is a common and clinically significant hem...
Status
Recruiting
Location
Konya City Hospital
Start Date
2026-07-01
Trial ID
NCT07642765
Treatments Being Tested
CareWell will enable the delivery of integrated healthcare to frail elderly...
Status
Unknown
Location
Higher or Secondary Education Establishments
Start Date
2015-01-01
Trial ID
NCT03042039
Treatments Being Tested
The Balance and Daily Life questionnaire (EVQ) observes the adaption of the...
Status
Completed
Location
CHU Nimes
Start Date
2018-01-30
Trial ID
NCT03343821
Treatments Being Tested
Antithrombotic drugs, which include antiplatelet and anticoagulant therapie...
Status
Completed
Location
Unité de gériatrie aiguë, hôpital Pitié-Salpêtrière (Pr Marc Verny)
Start Date
2021-05-29
Trial ID
NCT04932603
Treatments Being Tested
This study was conducted to evaluate the effect of a comprehensive health p...
Status
Completed
Location
Akdeniz University
Start Date
2023-06-15
Trial ID
NCT06064227
Treatments Being Tested
The frailty syndrome (FS) is characterized by a multifactorial clinical syn...
Status
Unknown
Location
Adriana Caldo
Start Date
2019-04-13
Trial ID
NCT04376463
Treatments Being Tested
Background: Delirium is one of the most frequent, relevant, and increasing ...
Status
Completed
Location
Germans Trias i Pujol Hospital
Start Date
2023-10-26
Trial ID
NCT07119385
Treatments Being Tested
Frailty is a key predictor of adverse outcomes in older surgical patients, ...
Status
Completed
Location
28 Fuxing Road, Haidian District
Start Date
2020-04-01
Trial ID
NCT07322809
This phase II trial tests how well pembrolizumab in addition to chemotherap...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-10-01
Trial ID
NCT07275216
Acute lymphoblastic leukemia (ALL) is characterized by the abnormal prolife...
Status
Recruiting
Location
Hospital General de México Dr. Eduardo Liceaga
Start Date
2025-07-23
Trial ID
NCT07258043